Zinc Excel Australia - English - Department of Health (Therapeutic Goods Administration)

zinc excel

mcpherson's consumer products pty ltd - pyridoxine hydrochloride, quantity: 60.78 mg (equivalent: pyridoxine, qty 50 mg); ascorbic acid, quantity: 750 mg; sodium ascorbate, quantity: 282.86 mg (equivalent: ascorbic acid, qty 250 mg); zinc glycinate, quantity: 163.2 mg (equivalent: zinc, qty 50 mg) - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; carnauba wax; colloidal anhydrous silica; purified water; macrogol 3350; chlorophyllin-copper complex - antioxidant/reduce free radicals formed in the body ; maintain/support collagen formation ; maintain/support collagen health ; maintain/support energy production ; helps maintain/support eye retina health ; maintain/support healthy eyesight/vision ; maintain/support healthy growth and development ; maintain/support hair health ; maintain/support hair strength/thickness ; maintain/support nail health/strength/thickness ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; helps maintain/support healthy blood sugar/glucose ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support immune system to fight illness ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support cognitive function/mental function ; maintain/support brain function ; maintain/support nerve conduction ; aid/assist/helps synthesis of neurotransmitters ; maintain/support reproductive system health ; maintain/support healthy reproductive hormones ; helps maintain/support testosterone formation/synthesis ; help maintain/support healthy prostate function ; maintain/support sperm production ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; maintain/support skin health ; maintain/support skin integrity/structure ; maintain/support wound healing ; maintain/support skin repair/healing/regeneration

Zinc Excel Australia - English - Department of Health (Therapeutic Goods Administration)

zinc excel

global therapeutics pty ltd - ascorbic acid,pyridoxine hydrochloride,sodium ascorbate,zinc glycinate -

Zinc Excel Australia - English - Department of Health (Therapeutic Goods Administration)

zinc excel

mcpherson's consumer products pty ltd - ascorbic acid,pyridoxine hydrochloride,sodium ascorbate,zinc glycinate -

MOUSEOFF ZINC PHOSPHIDE ECONOBAIT Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mouseoff zinc phosphide econobait

animal control technologies (australia) pty ltd - zinc phosphide - bait - zinc phosphide ungrouped active 25.0 g/kg - vertebrate poison - canola | grain crop | legume crop | nut crop | pasture | safflowers | high intensity usage | rapeseed - mouse - mus spp.

RIVASTIGMINE DEXCEL 1.5 MG Israel - English - Ministry of Health

rivastigmine dexcel 1.5 mg

dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.

RIVASTIGMINE DEXCEL 3 MG Israel - English - Ministry of Health

rivastigmine dexcel 3 mg

dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.

RIVASTIGMINE DEXCEL 4.5 MG Israel - English - Ministry of Health

rivastigmine dexcel 4.5 mg

dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.

RIVASTIGMINE DEXCEL 6 MG Israel - English - Ministry of Health

rivastigmine dexcel 6 mg

dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.

ACERIL 25 Israel - English - Ministry of Health

aceril 25

dexcel ltd, israel - captopril - tablets - captopril 25 mg - captopril - captopril - -hypertensioncongestive heart failure-insulin dependent diabetic nephropathy in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl.-improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less or equals to 40% and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients.

ACERIL 50 Israel - English - Ministry of Health

aceril 50

dexcel ltd, israel - captopril - tablets - captopril 50 mg - captopril - captopril - -hypertensioncongestive heart failure-insulin dependent diabetic nephropathy in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl.-improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less or equals to 40% and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients.